Bruker Corp (BRKR) Company Profile & Statistics

Bruker Corp
BRKR
(Nasdaq - US)
Open
49.23
-2.07 (-4.04%)
in:usd•As of: Nov 18, 2024 12:20 UTC -5
Open
51.17
High
51.49
Low
49.21

About Bruker Corp

CEO

Frank H. Laukien

Headquarters

40 manning road

billerica, ma 01821, united states

Auditor

PricewaterhouseCoopers LLP

Employees

9,707

Share Holders

Website

www.bruker.com

Industry

medical specialties

Sector

health technology

Company Overview

Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.

Bruker Corp Statistics

Valuation Measures

Market Capitalization ²	7.46B
Enterprise Value	9.61B
Enterprise Value/EBITDA (ttm)	21.23
Price to Earnings Ratio (ttm)	21.83
Price to Book (mrq)	4.26
Price to Sales (ttm)	2.40
Price to Cash (ytd)	14.36

Profitability

Gross Margin (ttm)	48.93%
Operating Margin (ttm)	10.72%
Profit Margin (ttm)	9.20%
Return on Equity (ttm)	21.52%
Return on Invested Capital (ttm)	11.05%
Return on Assets (ttm)	6.69%

Income Statement

Revenue (ttm)	3.24B
Revenue Per Share (ttm)	21.38
Gross Profit (ttm)	1.59B
EBITDA (ttm)³	452.70M
Net Income Avi to Common (ttm)	304.90M
Diluted EPS (ttm)	2.08

Share Statistics

Beta (5Y Monthly)	1.20
52-Week Change	-19.43%
S&P500 52-Week Change	29.65%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	151.60M
Dividend Yield	0.39%
Float ⁴	108.70M
% Held by Insiders	28.30%
% Held by Institutions	79.52%

Balance Sheet

Total Cash (mrq)	148.10M
Total Cash Per Share (mrq)	0.98
Total Debt (mrq)	2.30B
Total Debt/Equity (mrq)	125.87%
Current Ratio (mrq)	1.66%
Quick Ratio (mrq)	0.73%
Book Value Per Share (mrq)	12.04

Cash Flow

Operating Cash Flow Per Share (ytd)	0.40
Free Cash Flow (ytd)	-16.40M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Bruker Corp

Trade With A Regulated Broker